Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy

Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy

The combined inhibition of histone deacetylases (HDAC) and the proteins of the bromodomain and extraterminal (BET) family have recently shown therapeutic efficacy against melanoma, pancreatic ductal adenocarcinoma, testicular, and lymphoma cancers in murine studies. However, in such studies, the rol...

Descripció completa

Dades bibliogràfiques
Autors principals:	Badamchi-Zadeh, A, Moynihan, K, Larocca, R, Aid, M, Provine, N, Iampietro, M, Kinnear, E, Penaloza-Macmaster, P, Abbink, P, Blass, E, Tregoning, J, Irvine, D, Barouch, D
Format:	Journal article
Idioma:	English
Publicat:	American Association of Immunologists 2018

Ítems similars

Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy
per: Badamchi-Zadeh, Alexander, et al.
Publicat: (2020)

Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4(+) T cell responses that impair CD8(+) T cell function
per: Larocca, R, et al.
Publicat: (2016)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
per: Iampietro, M, et al.
Publicat: (2018)

Immediate dysfunction of vaccine-elicited CD8+ T cells primed in the absence of CD4+ T cells
per: Provine, N, et al.
Publicat: (2016)

Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization
per: Penaloza-MacMaster, P, et al.
Publicat: (2016)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
per: López-Camacho, C, et al.
Publicat: (2019)

Novel concepts for HIV vaccine vector design
per: Alayo, Q, et al.
Publicat: (2017)

Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
per: Wendy Mao, et al.
Publicat: (2019-10-01)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
per: César López-Camacho, et al.
Publicat: (2019-11-01)

Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
per: Provine, NM, et al.
Publicat: (2022)

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
per: Matthew J. Kling, et al.
Publicat: (2022-11-01)

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
per: Alexander S. Hölscher, et al.
Publicat: (2018-01-01)

The role of BET attenuation in melanoma
per: Henderson, EK
Publicat: (2020)

The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
per: Liu, G, et al.
Publicat: (2023)

Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
per: Penaloza MacMaster, P, et al.
Publicat: (2016)

Development of replication-competent adenovirus based vaccine vectors
per: Abbink P, et al.
Publicat: (2012-09-01)

Adenovirus vectors from various serotypes induce distinct cytokine profiles
per: Teigler JE, et al.
Publicat: (2012-09-01)

Combination BET Family Protein and HDAC Inhibition Synergistically Elicits Chondrosarcoma Cell Apoptosis Through RAD51-Related DNA Damage Repair
per: Huan S, et al.
Publicat: (2020-06-01)

THE IMPACT OF THE BETTING INDUSTRY ON SPORTS
per: Ioan TURCU, et al.
Publicat: (2020-12-01)

The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
per: Geng Liu, et al.
Publicat: (2023-01-01)

High-Yield Production of the Major Birch Pollen Allergen Bet v 1 With Allergen Immunogenicity in Nicotiana benthamiana
per: Yuki Yamada, et al.
Publicat: (2020-04-01)

Adjuvanted influenza vaccines
per: John S. Tregoning, et al.
Publicat: (2018-03-01)

A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.
per: Ekaterina Kinnear, et al.
Publicat: (2015-01-01)

What Is the BET on Solid Tumors?
per: Filippakopoulos, P
Publicat: (2018)

564 Single-cell transcriptomic analysis of immune compartments following combination immunotherapy treatment in poorly immunogenic tumors
per: Nir Hacohen, et al.
Publicat: (2021-11-01)

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts
per: Ashish Goyal, et al.
Publicat: (2023-10-01)

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses
per: Penaloza P, et al.
Publicat: (2012-09-01)

Clinical magnetocardiography: the unshielded bet—past, present, and future
per: D. Brisinda, et al.
Publicat: (2023-08-01)

Melanoma senescence: HDAC1 in focus.
per: Goding, C
Publicat: (2007)

Viral Hijacking of BET Proteins
per: Irene P. Chen, et al.
Publicat: (2022-10-01)

Chemical probes and inhibitors of bromodomains outside the BET family
per: Moustakim, M, et al.
Publicat: (2016)

Developing chemical probes for the BET bromodomains
per: Hewings, D, et al.
Publicat: (2012)

Betting on biotech :
per: Wong, Joseph, 1973-
Publicat: (2011)

BET223/BET306 – Insect Ecology (Ekologi Serangga)
per: PPSKJ, Pusat Pengajian Sains Kajihayat
Publicat: (2024)

Determinants of problem sports betting among college students: moderating roles of betting frequency and impulsive betting tendency
per: Yawen Shen
Publicat: (2023-10-01)

Cationic liposomes bearing Bet v 1 by coiled coil-formation are hypo-allergenic and induce strong immunogenicity in mice
per: Hans Warmenhoven, et al.
Publicat: (2023-01-01)

Bet v 1-displaying elastin-like polypeptide nanoparticles induce a strong humoral and weak CD4+ T-cell response against Bet v 1 in a murine immunogenicity model
per: Jolinde van Strien, et al.
Publicat: (2022-10-01)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
per: Liu J, et al.
Publicat: (2012-09-01)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
per: López-Camacho, C, et al.
Publicat: (2020)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
per: Elizabeth A. Thomas
Publicat: (2014-05-01)